Active Ingredient History

NOW
  • Now
Kappadione is a vitamin K derivative used for the treatment of side effects of vitamin K antagonists such as warfarin, prophylaxis and treatment of vitamin K deficiency bleeding, and hypoprothrombinemia due to various causes. It was manufactured by Eli Lilly and Company. Chemically, it is menadiol sodium diphosphate. It was approved by the US Food and Drug Administration prior to 1982 and marketed by Lilly. It has since been discontinued and is not available in North America.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Oral, Parenteral
  • Pro Drug: No
2-methyl-1,4-naphthalenediol | 2-methyl-1,4-naphthohydroquinone | 2-methyl-1,4-naphthoquinol | acetomenaphthone | acetomenaphtone | dihydrovitamin k3 | kapilon | kappadione | kappaxan | menadiol | menadiol, (-1)-ion | menadiol diphosphate | menadiol diphosphate ion | menadiol diphosphate, monosodium salt | menadiol diphosphate, tetrasodium salt | menadiol disodium disulfate | menadiol, monopotassium salt | menadiol potassium sulfate | menadiol sodium diphosphate | menadiol sodium diphosphate hexahydrate | menadiol sodium phosphate | menadiol sodium sulfate | menadiol sulfate | menadoxime | naphtadon | potassium menaphthosulfate | reduced menadione | synkavit | synkavite | synkayvite | vitamin k 4

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue